Peter Tygesen

Peter Tygesen is a seasoned business director with extensive experience in the pharmaceutical and biotechnology sectors. They began their career at Lundbeck, where they held roles such as Head of Dept. Process Development & Pilotplant R&D and Vice President of Pharmaceutical Production from 1994 to 1999. Peter further advanced their career as Divisional Director of Process Chemistry R&D at H. Lundbeck from 1999 to 2003, and as Chief Scientific Officer at EGALET LIMITED from 2008 to 2010. They served as Managing Director at Riemann A/S from 2011 to 2015 and were CEO of Brenntag Biosector from 2016 to 2019. Currently, Peter is the Director of Business Development at SPI Pharma, contributing their expertise to the industry. They hold both a Bachelor's and Master's Degree from Syddansk Universitet.